Skip to main content

ORIGINAL RESEARCH article

Front. Immunol., 23 June 2020
Sec. Inflammation
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.00907

RETRACTED: MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3

Retracted

A retraction of this article was approved in:

  1. Retraction: MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3

    1. Read retraction
\nJinpeng WangJinpeng Wang1Ping LiPing Li2Xiaofei XuXiaofei Xu3Beilin ZhangBeilin Zhang4Jing Zhang Jing Zhang1*
  • 1Department of Cardiology, The Second Hospital of Jilin University, Changchun, China
  • 2Department of Developmental Pediatrics, The Second Hospital of Jilin University, Changchun, China
  • 3Department of Radiology, The Second Hospital of Jilin University, Changchun, China
  • 4Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang J, Li P, Xu X, Zhang B and Zhang J (2020) MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3. Front. Immunol. 11:907. doi: 10.3389/fimmu.2020.00907

Received: 06 January 2020; Accepted: 20 April 2020;
Published: 23 June 2020; Retracted: 17 May 2024.

Edited by:

Guochang Hu, University of Illinois at Chicago, United States

Reviewed by:

Hongkuan Fan, Medical University of South Carolina, United States
Christine Noel Metz, Feinstein Institute for Medical Research, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.